Pulmonary hypertension and right ventricular dysfunction: Physiology and perioperative management

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 4, 2011, Pages 687-704

  Strumpher, Johann ^a   Jacobsohn, Eric ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

perioperative management; pulmonary hypertension; right ventricular dysfunction

Indexed keywords

BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; MILRINONE; NITRIC OXIDE; PROSTACYCLIN; PROSTANOID; SILDENAFIL; UNIPROST;

AEROBIC EXERCISE; BLALOCK HANLON OPERATION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; DEMOGRAPHY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; ENDARTERECTOMY; EXTRACORPOREAL CIRCULATION; HEART DISEASE; HEART LUNG TRANSPLANTATION; HEART OUTPUT; HEART RIGHT VENTRICLE DYSFUNCTION; HUMAN; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; PATHOGENESIS; PATHOLOGY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ENDARTERECTOMY; PULMONARY HYPERTENSION; REVIEW; RIGHT VENTRICULAR ASSIST DEVICE;

HUMANS; HYPERTENSION, PULMONARY; PERIOPERATIVE CARE; PROGNOSIS; PULMONARY ARTERY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 80052751471     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2011.02.022     Document Type: Review

References (167)

1. V. McLaughlin, and M. McGoon Pulmonary arterial hypertension Circulation 114 2006 1417 1431 (Pubitemid 44454562)
2. H. Farber, and J. Loscalzo Pulmonary arterial hypertension N Engl J Med 351 2004 655166
3. A.P. Fishman A century of pulmonary hemodynamics Am J Respir Crit Care Med 170 2004 109 113 (Pubitemid 38925154)
4. D. Taichman, and J. Mandel Epidemiology of pulmonary hypertension Clin Chest Med 28 2007 1 22
5. D.T. Dresdale, M. Schultz, and R.J. Michtom Primary pulmonary hypertension I, clinical and hemodynamic study Am J Med 11 1951 686 705
6. B. Riedel The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery Int Anesthesiol Clin 37 1999 55 79 (Pubitemid 29232929)
7. C.A. Wagenvoort, and H. Wagenvoort Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 classically diagnosed cases Circulation 42 1970 1163 1184
8. G. Simonneau, I. Robbins, and M. Beghetti Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 suppl 2009 S43 S53
9. N. Gali, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: ESC/ERS GUIDELINES Eur Heart J 30 2009 2493 2537
10. G. Kovacs, A. Berghold, and S. Scheidl Pulmonary arterial pressure during rest and exercise in healthy subjects A systematic review Eur Respir J 34 2009 888 894
11. B.D. Badesch, H.C. Champion, and M.A. Gomez-Sanchez Diagnosis and assessment of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S55 S56
12. V. McLaughlin, S.L. Archer, B.D. Badesch Writing Committee CCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
13. S. Hatano, and T. Strasser Primary Pulmonary Hypertension Report on a WHO Meeting. October 15-17, 1973 1975 World Health Organization Geneva
14. A.P. Fishman Clinical classification of pulmonary hypertension Clin Chest Med 22 2001 385 391 (Pubitemid 32912074)
15. G. Simonneau, N. Gali, and L.J. Rubin Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 2004 5S 12S (Pubitemid 38759712)
16. M. Humbert, O. Sitbon, and A. Chaouat Pulmonary arterial hypertension in France: Results from a national registry Am J Respir Crit Care Med 173 2006 1023 1030
17. A.M. Walker, D. Langleben, and J.J. Korelitz Temporal trends and drug exposures in pulmonary hypertension: An American experience Am Heart J 152 2006 521 526 (Pubitemid 44233427)
18. R.L. Benza, D.P. Miller, and M. Gomberg-Maitland Predicting survival in pulmonary arterial hypertension Insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 2010 1644172
19. J. Herget, J. Wilhelm, and J. Novotna A possible role of the oxidant tissue injury in the development of hypoxic pulmonary hypertension Physiol Res 49 2000 493 501
20. S. Archer, and S. Rich Primary pulmonary hypertension: A vascular biology and translational research "work in progress." Circulation 102 2000 2781 2791
21. S. Rich, D.R. Dantzker, and S.M. Ayres Primary pulmonary hypertension A national prospective study Ann Intern Med 107 1987 216 223 (Pubitemid 17137857)
22. R.C. Trembath, J.R. Thomson, and R.D. Machado Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia N Engl J Med 345 2001 325 334 (Pubitemid 32703235)
23. B.W. Christman, C.D. McPherson, and J.H. Newman An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension N Engl J Med 327 1992 70 75
24. C. Rubens, R. Ewert, and M. Halank Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension Chest 120 2001 1562 1569 (Pubitemid 33078473)
25. D.J. Stewart, R.D. Levy, and P. Cernacek Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann Intern Med 114 1991 464 469
26. L. Abenhaim, Y. Moride, and F. Brenot Appetite-suppressant drugs and the risk of primary pulmonary hypertension N Engl J Med 335 1996 609 616 (Pubitemid 26277950)
27. S. Eddahibi, M. Humbert, and E. Fadel Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension J Clin Invest 108 2001 1141 1150 (Pubitemid 32995372)
28. E. Marcos, S. Adnot, and M.H. Pham Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension Am J Respir Crit Care Med 168 2003 487 493 (Pubitemid 37046880)
29. J.M. Launay, P. Herve, and K. Peoc'h Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension Nat Med 8 2002 1129 1135 (Pubitemid 35175968)
30. A. Giaid, M. Yanagisawa, and D. Langleben Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 1732 1739 (Pubitemid 23170122)
31. W. Steudel, F. Ichinose, and P.L. Huang Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene Circ Res 81 1997 34 41 (Pubitemid 27272980)
32. V. Petkov, W. Mosgoeller, and R. Ziesche Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension J Clin Invest 111 2003 1339 1346 (Pubitemid 36554704)
33. M. Seeney, and J.X. Yuan Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels Respir Res 1 2000 40 48 (Pubitemid 34187892)
34. G. Simonneau, M. Fartoukh, and O. Sitbon Primary pulmonary hypertension associated with the use of fenfluramines derivatives Chest 114 suppl 3 1998 195S 199S (Pubitemid 28435967)
35. P.H. Schaiberger, T.C. Kennedy, and F.C. Miller Pulmonary hypertension associated with long-term inhalation of "crank methamphetamine Chest 104 1993 614 616 (Pubitemid 23229544)
36. R.M. Silver SclerodermaClinical problems: The lungs Rheum Dis Clin North Am 22 1996 825 840
37. R. Speich, R. Jenni, and M. Opravil Primary pulmonary hypertension in HIV infection Chest 100 1991 1268 1271
38. C.D. Cool, P.R. Rai, and M.E. Yeager Expression of human herpes virus 8 in primary pulmonary hypertension N Engl J Med 349 2003 1113 1122 (Pubitemid 37122323)
39. P.J. McDonnell, P.A. Toye, and G.M. Hutchins Primary pulmonary hypertension and cirrhosis: Are they related? Am Rev Respir Dis 127 1983 437 441 (Pubitemid 13083742)
40. Y.Y. Yang, H.C. Lin, and W.C. Lee Portopulmonary hypertension: Distinctive hemodynamic and clinical manifestations J Gastroenterol 36 2001 181 186
41. M. Castro, M.J. Krowka, and D.R. Schroeder Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients Mayo Clin Proc 71 1996 543 551
42. D. Molden, and J.L. Abraham Pulmonary hypertension: its association with hepatic cirrhosis and iron accumulation Arch Pathol Lab Med 106 1982 328 331 (Pubitemid 12048240)
43. D. Dingli, J.P. Utz, M.J. Krowka, A.L. Oberg, and A. Tefferi Unexplained pulmonary hypertension in chronic myeloproliferative disorders Chest 120 2001 801 808 (Pubitemid 32885453)
44. K.S. Marvin, and R.D. Spellberg Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia Chest 103 1993 642 644 (Pubitemid 23070789)
45. G. Hill, D. McClean, and R. Fraser Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia Aust N Z J Med 26 1996 852 853 (Pubitemid 127495281)
46. D. Grisaru, E.A. Rachmilewitz, and M. Mosseri Cardiopulmonary assessment in betathalassemia major Chest 98 1990 1138 1142
47. E.S. Klings, and H.W. Farber Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease Respir Res 2 2001 280 285 (Pubitemid 34189652)
48. V. Pengo, A.W. Lensing, and M.H. Prins Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism N Engl J Med 350 2004 2257 2264
49. M.M. Hoeper, E. Mayer, and G. Simonneau Chronic thromboembolic pulmonary hypertension Circulation 113 2006 2011 2020
50. O. Sitbon, M. Humbert, and X. Jais Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation 111 2005 3105 3111 (Pubitemid 40847788)
51. J. Morales-Blanhir, S. Santos, and L. de Jover Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension Respir Med 98 2004 225 234 (Pubitemid 38262656)
52. J. Pepke-Zaba, T.W. Higenbottam, and A.T. Dinh'Xuan Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension Lancet 338 1991 1173 1174
53. L.J. Rubin, B.M. Groves, and J.T. Reeves Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension Circulation 66 1982 334 338 (Pubitemid 12084983)
54. B.J. Schrader, S. Inbar, and L. Kaufmann Comparison of the effects of adenosine and nifedipine in pulmonary hypertension J Am Coll Cardiol 19 1992 1060 1064
55. D. Mereles, N. Ehlken, and S. Kreuscher Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension Circulation 114 2006 1482 1489 (Pubitemid 44527003)
56. L.C. Mohr Hypoxia during air travel in adults with pulmonary disease Am J Med Sci 335 2008 71 79
57. H. Frank, J. Mlczoch, and K. Huber The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension Chest 112 1997 714 721 (Pubitemid 27410708)
58. V. Fuster, P.M. Steele, and W.D. Edwards Primary pulmonary hypertension: Natural history and the importance of thrombosis Circulation 70 1984 580 587 (Pubitemid 14020655)
59. S. Rich, E. Kaufmann, and P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81
60. S. Rich, M. Seidlitz, and E. Dodin The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension Chest 114 1998 787 792 (Pubitemid 28433741)
61. R.J. Barst, L.J. Rubin, and W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension The Primary Pulmonary Hypertension Study Group N Engl J Med 334 1996 296 302
62. O. Sitbon, M. Humbert, and H. Nunes Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival J Am Coll Cardiol 40 2002 780 788 (Pubitemid 34925627)
63. D.B. Badesch, V.F. Tapson, and M.D. McGoon Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease A randomized, controlled trial Ann Intern Med 132 2000 425 434 (Pubitemid 30149039)
64. S. Cabrol, R. Souza, and X. Jais Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension J Heart Lung Transplant 26 2007 357 362 (Pubitemid 46522504)
65. V.V. McLaughlin, A. Shillington, and S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
66. S.M. Shapiro, R.J. Oudiz, and T. Cao Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion J Am Coll Cardiol 30 1997 343 349 (Pubitemid 27339311)
67. Centers for Disease Control and Prevention Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertensionSeven sites, United States, 2003-2006 MMWR Morb Mortal Wkly Rep 56 2007 170 172
68. K. Laliberte, C. Arneson, and R. Jeffs Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers J Cardiovasc Pharmacol 44 2004 209 214 (Pubitemid 38982164)
69. G. Simonneau, R.J. Barst, and N. Galie Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial Am J Respir Crit Care Med 165 2002 800 804 (Pubitemid 34229650)
70. H. Olschewski, G. Simonneau, and N. Galie Inhaled iloprost for severe pulmonary hypertension N Engl J Med 347 2002 322 329 (Pubitemid 34815354)
71. C.F. Opitz, R. Wensel, and J. Winkler Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension Eur Heart J 26 2005 1895 1902 (Pubitemid 41253303)
72. M.M. Hoeper, M. Schwarze, and S. Ehlerding Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue N Engl J Med 342 2000 1866 1870 (Pubitemid 30419050)
73. R.N. Channick, G. Simonneau, and O. Sitbon Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study Lancet 358 2001 1119 1123 (Pubitemid 32971843)
74. L.J. Rubin, D.B. Badesch, and R.J. Barst Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903 (Pubitemid 34984638)
75. V.V. McLaughlin, O. Sitbon, and D.B. Badesch Survival with first-line bosentan in patients with primary pulmonary hypertension Eur Respir J 25 2005 244 249 (Pubitemid 40246523)
76. N. Galie, M. Beghetti, and M.A. Gatzoulis Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study Circulation 114 2006 48 54 (Pubitemid 44305274)
77. X. Jais, A.M. D'Armini, and P. Jansa Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFit (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo- controlled trial J Am Coll Cardiol 52 2008 2127 2134
78. R.J. Barst, D. Langleben, and A. Frost Sitaxsentan therapy for pulmonary arterial hypertension Am J Respir Crit Care Med 169 2004 441 447 (Pubitemid 38187114)
79. A.C. Widlitz, R.J. Barst, and E.M. Horn Sitaxsentan: A novel endothelin-A receptor antagonist for pulmonary arterial hypertension Expert Rev Cardiovasc Ther 3 2005 985 991 (Pubitemid 41748366)
80. G.D. Lewis, R. Shah, and K. Shahzad Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension Circulation 116 2007 1555 1562 (Pubitemid 47511419)
81. N. Galie, H.A. Ghofrani, and A. Torbicki Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2005 2148 2157 (Pubitemid 41653106)
82. M.M. Hoeper, and T. Welte Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 354 2006 1091 1093
83. L.S. De Santo, C. Mastroianni, and G. Romano Role of sildenafil in acute posttransplant right ventricular dysfunction: Successful experience in 13 consecutive patients Transplant Proc 40 2008 2015 2018
84. J.E. Lee, S.C. Hillier, and C.A. Knoderer Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease J Intensive Care Med 23 2008 329 334
85. M.C. Aubin, S. Laurendeau, and A. Mommerot Differential effects of inhaled and intravenous sildenafil in the prevention of the pulmonary endothelial dysfunction due to cardiopulmonary bypass J Cardiovasc Pharmacol 51 2008 11 17
86. Y. Lamarche, O. Malo, and E. Thorin Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass J Thorac Cardiovasc Surg 130 2005 83 92 (Pubitemid 40941673)
87. A.F. Freitas Jr, and F. Bacal Jr Impact of sublingual sildenafil on pulmonary hypertension in patients with heart failure Arq Bras Cardiol 92 2009 116 126
88. S. Deveci, L. Pekirciolu, and C. Aygn Sublingual sildenafil in the treatment of erectile dysfunction: Faster onset of action with less dose Int J Urol 11 2004 989 992 (Pubitemid 39577195)
89. M. Humbert, R.J. Barst, and I.M. Robbins Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 Eur Respir J 24 2004 353 359 (Pubitemid 39232254)
90. M.M. Hoeper, H. Leuchte, and M. Halank Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension Eur Respir J 28 2006 691 694 (Pubitemid 46331988)
91. V.V. McLaughlin, R.J. Oudiz, and A. Frost Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension Am J Respir Crit Care Med 174 2006 1257 1263 (Pubitemid 44924827)
92. G. Simonneau, L.J. Rubin, and N. Galie Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: A randomized trial Ann Intern Med 149 2008 521 530
93. M. Gomberg-Maitland, V. McLaughlin, and M. Gulati Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension Am J Cardiol 96 2005 1334 1336 (Pubitemid 41505420)
94. W.E. Hopkins, L.L. Ochoa, and G.W. Richardson Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome J Heart Lung Transplant 15 1996 100 105 (Pubitemid 26056129)
95. W.E. Hopkins The remarkable right ventricle of patients with Eisenmenger syndrome Coron Artery Dis 16 2005 19 25 (Pubitemid 40279593)
96. R.L. Doyle, D. McCrory, and R.N. Channick Surgical treatments/ interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 2004 63S 71S (Pubitemid 38932342)
97. A. Micheletti, A.A. Hislop, and A. Lammers Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension Heart 92 2006 969 972 (Pubitemid 43974065)
98. L.R. Prieto, L.A. Latson, and C. Jennings Atrial septostomy using a butterfly stent in a patient with severe pulmonary arterial hypertension Catheter Cardiovasc Interv 68 2006 642 647 (Pubitemid 44546061)
99. N. Esp'nola-Zavaleta, J. Vargas-Barro'n, and J.I. Tazar Echocardiographic evaluation of patients with primary pulmonary hypertension before and after atrial septostomy Echocardiography 16 1999 625 634 (Pubitemid 29483228)
100. F. Reichenberger, J. Pepke-Zaba, and K. McNeil Atrial septostomy in the treatment of severe pulmonary arterial hypertension Thorax 58 2003 797 800 (Pubitemid 37094058)
101. A. Rothman, M.S. Sklansky, and V.W. Lucas Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension Am J Cardiol 84 1999 682 686 (Pubitemid 29417961)
102. J. Lewczuk, P. Piszko, and J. Jagas Prognostic factors in medically treated patients with chronic pulmonary embolism Chest 119 2001 818 823 (Pubitemid 32197654)
103. P.A. Thistlethwaite, K. Kaneko, and M.M. Madani Techniques and outcomes of pulmonary endarterectomy surgery Ann Thorac Cardiovasc Surg 14 2008 274 282
104. K.M. Moser, and C.M. Bloor Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension Chest 103 1993 685 692 (Pubitemid 23086157)
105. E.S. Yi, H. Kim, and H. Ahn Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension: A morphometric and immunohistochemical study Am J Respir Crit Care Med 162 2000 1577 1586
106. N.H. Kim Assessment of operability in chronic thromboembolic pulmonary hypertension Proc Am Thorac Soc 3 2006 584 588 (Pubitemid 44411624)
107. S.W. Jamieson, D.P. Kapelanski, and N. Sakakibara Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases Ann Thorac Surg 76 2003 1457 1464 (Pubitemid 37378293)
108. E. Mayer, and W. Klepetko Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension Proc Am Thorac Soc 3 2006 589 593 (Pubitemid 44411625)
109. J.D. Christie, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult lung and heart/lung transplantation report2008 J Heart Lung Transplant 27 2008 957 969
110. J.B. Orens, M. Estenne, S. Arcasoy Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation International guidelines for the selection of lung transplant candidates: 2006 updateA consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 25 2006 745 755 (Pubitemid 43963375)
111. Y. Toyoda, J. Thacker, and R. Santos Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension Ann Thorac Surg 86 2008 1116 1122
112. S.M. Kawut, D.B. Taichman, and C.L. Archer-Chicko Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis Chest 123 2003 344 350 (Pubitemid 36269414)
113. M.R. Nihill, M.P. O'Laughlin, and C.E. Mullins Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease Catheter Cardiovasc Diagn 24 1991 166 172
114. D. Kerstein, P.S. Levy, and D.T. Hsu Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension Circulation 91 1995 2028 2035
115. T.K. Waddell, L. Bennett, and R. Kennedy Heart-lung or lung transplantation for Eisenmenger syndrome J Heart Lung Transplant 21 2002 731 737 (Pubitemid 34718178)
116. S.R. Cottini, N. Lerch, and M. de Perrot Risk factors for reperfusion injury after lung transplantation Intensive Care Med 32 2006 557 563
117. Y. Toyoda, J. Thacker, and R. Santos Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension Ann Thorac Surg 86 2008 1116 1122
118. E.P. Trulock, L.B. Edwards, D.O. Taylor International Society for Heart and Lung Transplantation: Registry of the International Society for Heart and Lung Transplantation Twenty third official adult lung and heart lung transplantation report J Heart Lung Transplant 25 2006 880 892
119. P. Maggio, M. Hemmila, and J. Haft Extracorporeal life support for massive pulmonary embolism J Trauma 62 2007 570 576 (Pubitemid 46568852)
120. D. Vlasselaers, G.M. Verleden, and B. Meyns Femoral venoarterial extracorporeal membrane oxygenation for severe reimplantation response after lung transplantation Chest 118 2000 559 561 (Pubitemid 30637835)
121. P.A. Thistlethwaite, M.M. Madani, and A.D. Kemp Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes Ann Thorac Surg 82 2006 2139 2145
122. S.A. Conrad, P.T. Rycus, and H. Dalton Extracorporeal Life Support Registry Report 2004 ASAIO J 51 2005 4 10 (Pubitemid 40165243)
123. G.E. D'Alonzo, R.J. Barst, and S.M. Ayres Survival in patients with primary pulmonary hypertension Results from a national prospective registry Ann Intern Med 115 1991 343 349
124. A.M. Stupi, V.D. Steen, and G.R. Owens Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis Arthritis Rheum 29 1986 515 524 (Pubitemid 16118701)
125. K.P. Kuhn, D.W. Byrne, and P.G. Arbogast Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol Am J Respir Crit Care Med 167 2003 580 586
126. N. Galie, A. Manes, and L. Negro A meta-analysis of randomized controlled trials in pulmonary arterial hypertension Eur Heart J 30 2009 394 403
127. A. Macchia, R. Marchioli, and R. Marfisi A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology Am Heart J 153 2007 1037 1047 (Pubitemid 46809838)
128. G. Ramakrishna, J. Sprung, and B.S. Ravi Impact of pulmonary hypertension on the outcomes of noncardiac surgery: Predictors of perioperative morbidity and mortality J Am Coll Cardiol 45 2005 1691 1699 (Pubitemid 40704508)
129. G. Blaise, D. Langleben, and B. Hubert Pulmonary arterial hypertension: Pathophysiology and anesthetic approach Anesthesiology 99 2003 1415 1432 (Pubitemid 37475190)
130. J.T. Martin, T.J. Tautz, and J.F. Antognini Safety of regional anesthesia in Eisenmenger's syndrome Reg Anesth Pain Med 27 2002 509 513
131. M.J. Krowka, M.S. Mandell, and M.A. Ramsay Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database Liver Transpl 10 2004 174 182 (Pubitemid 38240114)
132. T. Nishikawa, and S. Dohi Errors in the measurement of cardiac output by thermodilution Can J Anaesth 40 1993 142 153 (Pubitemid 23094716)
133. M. Balik, J. Pachl, and J. Hendl Effect of the degree of tricuspid regurgitation on cardiac output measurements by thermodilution Intensive Care Med 8 2002 1117 1121
134. P.M. Heerdt, G.A. Blessios, and M.L. Beach Flow dependency of error in thermodilution measurement of cardiac output during acute tricuspid regurgitation Cardiothorac Vasc Anesth 15 2001 183 187 (Pubitemid 32295315)
135. G. Szabo, P. Soos, and S. Bahrle Adaptation of the right ventricle to an increased afterload in the chronically volume overloaded heart Ann Thorac Surg 82 2006 989 995
136. E.B. Braun, C.A. Palin, and C.W. Hogue Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol Anesth Analg 99 2004 36 37 (Pubitemid 38808159)
137. L.C. Price, P. Forrest, and V. Sodhi Use of vasopressin after caesarean section in idiopathic pulmonary arterial hypertension Br J Anaesth 99 2007 552 555 (Pubitemid 47412500)
138. G. Poelzl, R.H. Zwick, and W. Grander Safety and effectiveness of levosimendan in patients with predominant right heart failure Herz 33 2008 368 373
139. F. Kerbaul, B. Rondelet, and J.P. Demester Effects of levosimendan versus dobutamine on pressure loadinduced right ventricular failure Crit Care Med 34 2006 2814 2819 (Pubitemid 44610948)
140. J.E. Calvin Jr Inotropic therapy for the failed heart: Picking the right drug for the job Cardiothorac Vasc Anesth Update 10 1991 1 13
141. R.J. Damiano, T. Asano, and P.K. Smith Functional consequences of right ventricular isolation procedure J Thorac Cardiovasc Surg 100 1990 569 579 (Pubitemid 20347129)
142. S. Saleh, O.J. Liakopoulos, and G.D. Buckberg The septal motor of biventricular function Eur J Cardiothorac Surg 29 suppl 1 2006 S126 S138
143. R.J. Damiano, P. La Follette Jr, and J.L. Cox Significant left ventricular contribution to right ventricular systolic function Am J Physiol 261 1991 H1514 H1524
144. I. Belenkie, S.G. Horne, and R. Dani Effects of aortic constriction during experimental acute right ventricular pressure loading Further insights into diastolic and systolic ventricular interaction Circulation 92 1995 546 554
145. R.J. Damiano, J.L. Cox, and J.E. Lowe Left ventricular pressure effects on right ventricular pressure and volume outflow Cathet Cardiovasc Diagn 19 1990 269 278 (Pubitemid 20195392)
146. Z. Ziskind, L. Pohoryles, and R. Mohr The effect of low-dose intravenous nitroglycerine on pulmonary hypertension immediately after replacement of a stenotic mitral valve Circulation 72 1985 164 169
147. F.E. Barr, R.G. Tirona, and M.B. Taylor Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: Potential therapy for postoperative pulmonary hypertension J Thorac Cardiovasc Surg 134 2007 319 326 (Pubitemid 47088581)
148. S.M. Lowson Alternatives to nitric oxide Br Med Bull 70 2004 119 131 (Pubitemid 40069376)
149. M. D'Ambra, P.J. LaRaia, and D.M. Philbin Prostaglandin E1A new therapy for refractory right ventricular failure and pulmonary hypertension after mitral valve replacement J Thorac Cardiovasc Surg 89 1985 567 572 (Pubitemid 16240103)
150. Y. Lamarche, L.P. Perrault, and S. Maltais Preliminary experience with inhaled milrinone in cardiac surgery Eur J Cardiothorac Surg 31 2007 1081 1087 (Pubitemid 46729654)
151. S.P. Salzberg, F. Filsoufi, and A. Anyanwu High-risk mitral valve surgery: Perioperative hemodynamic optimization with nesiritide (BNP) Ann Thorac Surg 80 2005 502 506 (Pubitemid 41019468)
152. M.J. Semigran Hemodynamic effects of inhaled mitric oxide in heart failure Am J Coll Cardiol 24 1994 982 988 (Pubitemid 24306408)
153. M.C. Oz, and A. Ardehali Collective review: Perioperative uses of inhaled nitric oxide in adults Heart Surg Forum 7 2004 E584 E589
154. Y. Fujita, O. Nishida, and K. Sobue Nitric oxide inhalation is useful in the management of right ventricular failure caused by myocardial infarction Crit Care Med 30 2002 1379 1381 (Pubitemid 34620987)
155. I. Inglessis Hemodynamic effects of inhaled nitric oxide in right ventricular infarction and cardiogenic shock J Am Coll Cardiol 44 2004 793 798 (Pubitemid 39099575)
156. K. Fattouch, F. Sbraga, and R. Sampognaro Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study J Cardiovasc Med (Hagerstown) 7 2006 119 123 (Pubitemid 44152952)
157. C.J. DeWet, D.G. Affleck, and E. Jacobsohn Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery J Thorac Cardiovasc Surg 127 2004 1058 1067 (Pubitemid 38451939)
158. A. Haraldsson Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance Chest 114 1998 780 786 (Pubitemid 28433740)
159. W. Steudel, W.E. Hurford, and W.M. Zapol Inhaled nitric oxide: Basic biology and clinical application Anesthesiology 91 1999 1090 1121 (Pubitemid 29466545)
160. D. Walmrath, T. Schneider, and R. Schermuly Direct comparison of nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome Am J Respir Crit Care Med 153 1996 991 996 (Pubitemid 26081651)
161. S. Rex, C. Missant, and P. Claus Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: A randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension Crit Care 12 2008 R113
162. M. Winterhalter, A. Simon, and S. Fischer Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: A prospective randomized trial J Cardiothorac Vasc Anesth 22 2008 406 413
163. H. Wang, M. Gong, and B. Zhou Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery Adv Ther 26 2009 462 468
164. D.N. Cornfield, E.B. Martin, and V. Hampl Aerosol delivery of diethylene-triamine/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs J Lab Clin Med 134 1999 419 425 (Pubitemid 29492163)
165. C.F. Lam, P.V. Van Heerden, and J. Blott The selective pulmonary vasodilatory effect of inhaled DETA/NO, a novel nitric oxide donor, in ARDSA pilot human trial J Crit Care 19 2004 48 53 (Pubitemid 38525976)
166. P. Goyal, U. Kiran, and S. Chauhan Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease Br J Anaesth 97 2006 208 214 (Pubitemid 44295707)
167. J.J. Lepore Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: Combined administration with inhaled nitric oxide Chest 127 2005 1647 1653 (Pubitemid 46218790)